EPISODE · Nov 19, 2020 · 18 MIN
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France
from Decera Clinical Education Oncology Podcast · host Alain Ravaud MD PhD, Marine Gross-Goupil MD PhD
In this episode, Alain Ravaud, MD, PhD, and Marine Gross-Goupil, MD, PhD, discuss in French the latest immuno-oncology developments in the treatment of urothelial cancer. Presenters:Alain Ravaud, MD, PhD Professor of Medical OncologyHead of Department of Medical OncologyBordeaux University HospitalBordeaux, FranceMarine Gross-Goupil, MD, PhD Medical OncologistSaint-André HospitalBordeaux University HospitalBordeaux, FranceContent based on an online IME program supported by educational grants from EMD Serono, Inc and Pfizer.Link to full program:https://bit.ly/3kJC5SL Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Embed this episode
What this episode covers
Listen to Alain Ravaud, MD, PhD, and Marine Gross-Goupil, MD, PhD, discuss in French the latest clinical data on immune checkpoint inhibitors for advanced urothelial cancer.
Ready to play
Incorporating Immune Checkpoint Inhibitors Into Practice for Advanced Urothelial Cancer: Expert Perspectives From France
No transcript for this episode yet
Similar Episodes
No similar episodes found.